Lisa Gill
Stock Analyst at JP Morgan
(2.40)
# 2,423
Out of 4,711 analysts
126
Total ratings
44.05%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Downgrades: Neutral | $18 | $13.01 | +38.36% | 2 | Dec 17, 2024 | |
| INNV InnovAge Holding | Downgrades: Underweight | $5 | $4.19 | +19.33% | 4 | Dec 17, 2024 | |
| SGRY Surgery Partners | Maintains: Neutral | $38 → $28 | $21.22 | +31.95% | 4 | Dec 3, 2024 | |
| PRVA Privia Health Group | Maintains: Overweight | $27 → $28 | $20.07 | +39.51% | 4 | Nov 29, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Overweight | $20 → $15 | $9.55 | +57.07% | 14 | Aug 30, 2024 | |
| TDOC Teladoc Health | Maintains: Neutral | $16 → $9 | $9.44 | -4.66% | 9 | Aug 26, 2024 | |
| OMI Owens & Minor | Maintains: Underweight | $22 → $18 | $12.52 | +43.77% | 4 | Aug 21, 2024 | |
| MCK McKesson | Maintains: Overweight | $656 → $661 | $579.74 | +14.02% | 13 | Aug 21, 2024 | |
| HUM Humana | Maintains: Neutral | $332 → $396 | $247.10 | +60.26% | 5 | Aug 21, 2024 | |
| CI The Cigna Group | Maintains: Overweight | $435 → $438 | $276.92 | +58.17% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $287 | $227.69 | +26.05% | 1 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $111 → $123 | $118.28 | +3.99% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $20.03 | +44.78% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $16.01 | +12.43% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $294.73 | +34.02% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $228.61 | +6.29% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $101 → $86 | $44.36 | +93.87% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $180.11 | +3.27% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $546 → $559 | $500.13 | +11.77% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $129.46 | +8.14% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $152 → $155 | $153.10 | +1.24% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $303.62 | +9.35% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $365.96 | +72.42% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.44 | +125.23% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.97 | +356.85% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.58 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.29 | +9.74% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $46 → $44 | $22.91 | +92.06% | 2 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $69.82 | +18.88% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $10 | $10.61 | -5.75% | 3 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $59.58 | +64.48% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $24 | $30.86 | -22.23% | 4 | Jun 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.76 | - | 4 | Dec 19, 2017 |
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $13.01
Upside: +38.36%
InnovAge Holding
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $4.19
Upside: +19.33%
Surgery Partners
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.22
Upside: +31.95%
Privia Health Group
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $20.07
Upside: +39.51%
Walgreens Boots Alliance
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $9.55
Upside: +57.07%
Teladoc Health
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $9.44
Upside: -4.66%
Owens & Minor
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $12.52
Upside: +43.77%
McKesson
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $579.74
Upside: +14.02%
Humana
Aug 21, 2024
Maintains: Neutral
Price Target: $332 → $396
Current: $247.10
Upside: +60.26%
The Cigna Group
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $276.92
Upside: +58.17%
Aug 21, 2024
Maintains: Overweight
Price Target: $280 → $287
Current: $227.69
Upside: +26.05%
Aug 21, 2024
Maintains: Neutral
Price Target: $111 → $123
Current: $118.28
Upside: +3.99%
Aug 19, 2024
Initiates: Overweight
Price Target: $29
Current: $20.03
Upside: +44.78%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $16.01
Upside: +12.43%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $294.73
Upside: +34.02%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $228.61
Upside: +6.29%
May 30, 2024
Maintains: Overweight
Price Target: $101 → $86
Current: $44.36
Upside: +93.87%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $180.11
Upside: +3.27%
May 30, 2024
Maintains: Overweight
Price Target: $546 → $559
Current: $500.13
Upside: +11.77%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $129.46
Upside: +8.14%
May 30, 2024
Maintains: Neutral
Price Target: $152 → $155
Current: $153.10
Upside: +1.24%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $303.62
Upside: +9.35%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $365.96
Upside: +72.42%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.44
Upside: +125.23%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.97
Upside: +356.85%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.58
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.29
Upside: +9.74%
Oct 18, 2023
Maintains: Overweight
Price Target: $46 → $44
Current: $22.91
Upside: +92.06%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $69.82
Upside: +18.88%
Jul 7, 2023
Maintains: Neutral
Price Target: $12 → $10
Current: $10.61
Upside: -5.75%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $59.58
Upside: +64.48%
Jun 7, 2018
Maintains: Underweight
Price Target: $26 → $24
Current: $30.86
Upside: -22.23%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $21.76
Upside: -